About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...

The company forecast flat to 2% growth in 2025 per share adjusted profit, compared with $1.14 it earned in 2024. Analysts ...

Understanding enterprise data is the secret sauce in PTC's blueprint for applying practical, value-based AI, argues Barua.

Petrobras’ shipping arm, Transpetro, has more than doubled the number of suezmax dynamic positioning two (DP2) shuttle tanker ...

Founded in 2001 by the Financial Services and Markets Act 2000, the organization is independent of the government and the ...

China buys nearly half of U.S. ethane exports, according to the U.S. Energy Information Administration, which sees U.S. net ...

Abu Dhabi-listed Al Seer Marine has revealed that two more of its recently delivered chemical/product tanker newbuildings have been placed on five-year time-charters to the Middle East arm of Indian ...

In a matter of hours, USPS suspended and then resumed accepting packages from China and Hong Kong after Trump's tariffs went ...

The post contains 50 new customer stories, which appear at the beginning of each section of customer lists. The post will be ...

Viable cordless alternatives were demonstrated for handling rebar, concrete and everything in between from Bosch, DeWalt, ...

I didn’t leave Labour. Labour left us,” is a common sentiment in working-class communities across Britain. Member of ...

Empowering Law Firms & Capital Providers with a Modernized Experience WILLIAMSVILLE, NEW YORK / ACCESS Newswire / February 5, 2025 / Counsel ...